\n| Subject<\/td>\n | \nAnnouncement for subsidiary Excelsior Medical (HK) Co.,\r\nLtd. regarding the organizational restructuring and share\r\nexchange of its investee, Asia Best Healthcare. Co., Ltd.<\/pre>\n<\/td>\n<\/tr>\n\n| Date of events<\/td>\n | 2022\/10\/27<\/td>\n | To which item it meets<\/td>\n | paragraph 20<\/td>\n<\/tr>\n | \n| Statement<\/td>\n | \n1.Name and nature of the underlying assets (if preferred \r\n shares, the terms and conditions of issuance shall also \r\n be indicated, e.g., dividend yield,etc.):\r\n 1.Asia Best Healthcare Co.,Ltd. shall repurchase its own\r\n common shares from Excelsior Medical (HK) Co., Limited.\r\n 2.Excelsior Medical (HK) Co., Limited. shall acquire \r\n common shares of ASIA BEST LIFE CARE TECHNOLOGY CO., \r\n LTD.( the subsidiary of Asia Best Healthcare Co.,Ltd.)\r\n for consideration.\r\n2.Date of occurrence of the event:2022\/10\/27\r\n3.Amount, unit price, and total monetary amount of the \r\n transaction:\r\n 1. Based on the net worth in 2022\/05\/31 financial report \r\n of Asia Best Healthcare Co.,Ltd., Asia Best Healthcare\r\n Co.,Ltd. repurchases its own 1 share from the original\r\n shareholders and exchanges its subsidiary ASIA BEST \r\n LIFE CARE TECHNOLOGY CO., LTD. common stock 404.35 \r\n shares.\r\n 2.Asia Best Healthcare Co.,Ltd. buybacks its own common \r\n shares 209,308 shares from Excelsior Medical (HK) Co., \r\n Limited. and Excelsior Medical (HK) Co.,Limited. \r\n acquires common shares 84,633,340 shares of ASIA BEST\r\n LIFE CARE TECHNOLOGY CO., LTD. for consideration.\r\n 3.Based on the 2022\/05\/31 financial report of Asia Best \r\n Healthcare Co.,Ltd.,the per share net worth of ASIA \r\n BEST LIFE CARE TECHNOLOGY CO., LTD. is NTD 10.2954, \r\n the amount of the total shares of ASIA BEST LIFE CARE\r\n TECHNOLOGY CO.,LTD.acquired by Excelsior Medical (HK)\r\n Co., Limited.is NTD871,334 thousands.\r\n4.Trading counterparty and its relationship with the\r\n Company (if the trading counterparty is a natural \r\n person and furthermore is not a related party of the \r\n Company, the name of the trading counterparty is not\r\n required to be disclosed):\r\n Both Asia Best Healthcare Co.,Ltd.and ASIA BEST LIFE \r\n CARE TECHNOLOGY CO., LTD. are the related party of the\r\n company.\r\n5.Where the trading counterparty is a related party, \r\n announcement shall also be made of the reason for \r\n choosing the related party as trading counterparty\r\n and the identity of the previous owner, its \r\n relationship with the Company and the trading \r\n counterparty, and the previous date and monetary amount \r\n of transfer:\r\n Asia Best Healthcare Co.,Ltd. reorganizes the \r\n organizational structure. The identity of the previous\r\n owner, its relationship with the Company and the trading\r\n counterparty, and the previous date and monetary amount \r\n of transfer: Not Applicable.\r\n6.Where an owner of the underlying assets within the past\r\n five years has been a related party of the Company, the \r\n announcement shall also include the date and price of\r\n acquisition and disposal by the related party, and its\r\n relationship with the Company at the time of the \r\n transaction:Not Applicable.\r\n7.Matters related to the current disposal of creditors'\r\n rights (including types of collaterals of the disposed\r\n creditor\u2019s rights; if creditor's rights over a related \r\n party, announcement shall be made of the name of the\r\n related party and the book amount of the creditor's \r\n rights, currently being disposed of, over such related \r\n party):Not Applicable.\r\n8.Profit or loss from the disposal (not applicable in \r\n cases of acquisition of securities) (those with \r\n deferral should provide a table explaining recognition):\r\n Not Applicable.\r\n9.Terms of delivery or payment (including payment period \r\n and monetary amount), restrictive covenants in the \r\n contract, and other important terms and conditions:\r\n Terms of delivery or payment: Not Applicable.\r\n Conditions precedent to closing:\r\n Asia Best Healthcare Co.,Ltd. will reduce its share \r\n capital after completion of statutory procedures, \r\n Excelsior Medical (HK) Co., Limited. will acquire\r\n common shares of ASIA BEST LIFE CARE TECHNOLOGY CO., \r\n LTD.\r\n The unit price, and total monetary amount of the \r\n transaction will be changed on the settlement date.\r\n10.The manner of deciding on this transaction (such as\r\n invitation to tender, price comparison, or price \r\n negotiation), the reference basis for the decision \r\n on price, and the decision-making unit:\r\n The manner of deciding on this transaction: To be \r\n decided by Asia Best Healthcare Co.,Ltd.'s \r\n sharesholders'meeting resolution. \r\n The reference basis for the decision on price: \r\n Opinion on the reasonablesness of the Share Exchange\r\n ratio issued by Integritas CPA Firm.\r\n The decision-making department\uff1aAsia Best Healthcare \r\n Co.,Ltd.'s sharesholders'meeting.\r\n11.Net worth per share of the Company's underlying \r\n securities acquired or disposed of:Not Applicable.\r\n12.Cumulative no.of shares held (including the current\r\n transaction), their monetary amount, shareholding \r\n percentage, and status of any restriction of rights\r\n (e.g., pledges), as of the present moment:\r\n Cumulative no. of shares held:\r\n Asia Best Healthcare Co.,Ltd.:129,492 common shares.\r\n ASIA BEST LIFE CARE TECHNOLOGY CO.,LTD.:84,633,340 \r\n common shares.\r\n Cumulative monetary amount:\r\n Asia Best Healthcare Co.,Ltd.\uff1aUSD19,484,706.\r\n ASIA BEST LIFE CARE TECHNOLOGY CO.,LTD.:USD32,110,038.\r\n Shareholding percentage\uff1a\r\n The final figure depends on the willingness of Asia \r\n Best Healthcare Co.,Ltd.'s original shareholders for\r\n share exchange.\r\n restriction of rights: None.\r\n13.Current ratio of securities investment (including the\r\n current trade, as listed in article 3 of Regulations\r\n Governing the Acquisition and Disposal of Assets by\r\n Public Companies) to the total assets and equity\r\n attributable to owners of the parent as shown in the\r\n most recent financial statement and working capital as\r\n shown in the most recent financial statement as of the\r\n present:\r\n Ratio to total assets:28.78%\r\n Ratio to shareholders'equity of the parent company: \r\n 33.43%\r\n Amount of working capital:\uff1aNTD 1,150,828 thousands.\r\n14.Broker and broker's fee:Not Applicable.\r\n15.Concrete purpose or use of the acquisition or disposal:\r\n The organizational restructuring of Asia Best \r\n Healthcare Co.,Ltd.\r\n16.Any dissenting opinions of directors to the present \r\n transaction:NO.\r\n17.Whether the counterparty of the current transaction \r\n is a related party:YES.\r\n18.Date of the board of directors resolution:2022\/10\/27\r\n19.Date of ratification by supervisors or approval by the \r\n Audit Committee:NA\r\n20.Whether the CPA issued an unreasonable opinion \r\n regarding the current transaction:Not Applicable.\r\n21.Name of the CPA firm:Integritas CPA Firm.\r\n22.Name of the CPA:Wu-Hung-Yi\r\n23.Practice certificate number of the CPA:\r\n CPA Associations R.O.C.(Taiwan) No.1070015\r\n24.Whether the transaction involved in change of business \r\n model:NO.\r\n25.Details on change of business model:Not Applicable.\r\n26.Details on transactions with the counterparty for the \r\n past year and the expected coming year:Not Applicable.\r\n27.Source of funds:Not Applicable.\r\n28.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":" SEQ_NO \u00a03 Date of announcement \u00a02022\/10\/27 Time of announcement 18:43:26 Subject Announcement for subsidiary Excelsior Medical (HK) Co., Ltd. regarding the organizational restructuring and share exchange of its investee, Asia Best Healthcare. Co., Ltd. Date of events 2022\/10\/27 To which item it meets paragraph 20 Statement 1.Name and nature of the underlying assets (if …<\/p>\n Announcement for subsidiary Excelsior Medical (HK) Co., Ltd. regarding the organizational restructuring and share exchange of its investee, Asia Best Healthcare. Co., Ltd.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-6403","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=6403"}],"version-history":[{"count":11,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6403\/revisions"}],"predecessor-version":[{"id":6416,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6403\/revisions\/6416"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=6403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=6403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=6403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} | |